RSLS - ReShape Lifesciences Inc.
0.3536
-0.091 -25.848%
Share volume: 4,952,846
Last Updated: 05-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.44
-0.09
-0.21%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 1.944 M | 1.965 M | 2.292 M | |
| Cost of revenue | 779.000 K | 831.000 K | 853.000 K | |
| Gross profit | 1.165 M | 1.134 M | 1.439 M | |
| -2.66% | 26.90% | |||
| Operating expenses | 3.375 M | 3.188 M | 3.200 M | |
| Selling general and admin | 2.891 M | 2.789 M | 2.801 M | |
| Research and development | 484.000 K | 399.000 K | 399.000 K | |
| Total expenses | 3.375 M | 3.188 M | 3.200 M | |
| -5.54% | 0.38% | |||
| Operating income | -2.210 M | -2.054 M | -1.761 M | |
| Ebit | -2.188 M | -2.013 M | -1.575 M | |
| Pretax income | -2.179 M | -1.580 M | -1.575 M | |
| -27.49% | -0.32% | |||
| Income tax | 14.000 K | 15.000 K | 6.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -2.193 M | -1.595 M | -1.581 M | |
| 27.27% | 0.88% |
